PA
WEN icon

PharVision Advisers’s Wendy's WEN Stock Holding History

PharVision Advisers’s Portfolio WEN Stock Details WEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,068
Closed -$97.8K – 136
2026
Q1 		$97.8K Buy
+14,068
New +$108K 0.99% 51
2025
Q1 		– Sell
-32,507
Closed -$530K – 529
2024
Q4 		$530K Buy
+32,507
New +$593K 0.45% 35

Other funds holding WEN

TFM
Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $2.64B AUM 24.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's WEN Position: Q2 2026 in Review

PharVision Advisers sold out of Wendy's (WEN) in Q2 2026, closing a stake of 14,068 shares — an estimated $97.8K sold.

PharVision Advisers first reported a position in WEN in Q4 2024 and held it in 2 quarters. The position peaked at $530K in Q4 2024. 403 funds tracked by Wall St. Rank hold WEN as of Q2 2026.

  • PharVision Advisers reported no remaining Wendy's position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 14,068 Wendy's shares in Q2 2026, an estimated $97.8K.
  • PharVision Advisers first reported a position in Wendy's in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Wendy's position peaked at $530K in Q4 2024.
  • 403 funds tracked by Wall St. Rank held Wendy's as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.